Chronic Disease Prevention Overview

Principles

Definition

Chronic disease prevention is the multi-disciplinary research area and public health strategy focused on the identification of modifiable risk factors and the development, evaluation, and implementation of interventions designed to avert the development or progression of chronic, non-communicable diseases within populations. This field investigates the determinants of long-term health conditions and seeks effective methods to reduce their incidence and prevalence, thereby improving population health outcomes and reducing disease burden.

Ontological type

Intervention Strategies

Risk Factor Frameworks

Policy and Governance

Key developments

Key Figures

Research-to-Practice Translation era

Barbara K. Rimer [1] was affiliated with Duke University [3] and Wake Forest University [4] during the Research-to-Practice Translation era (1984–2002). Her contributions in this era include advancing theory-to-practice in health education through Health Behavior and Health Education: Theory, Research, and Practice [7], which clarified how behavioral theory informs school, clinical, and community interventions and underscored the need for standardized metrics and surveillance. Karen Glanz [2] was affiliated with Harvard University [5] and University of Minnesota [6] during the Research-to-Practice Translation era. Her contributions likewise emphasize translating surveillance, multilevel interventions, and social determinants into practice, as reflected in Health Behavior and Health Education: Theory, Research, and Practice [7], shaping population-level strategies for schools, clinics, and communities.

Surveillance and Prioritization era

John J.V. McMurray [1], associated with Harvard University [3] and the University of California, San Francisco [4], contributed to the European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) [6]. This work helped standardize prevention recommendations across Europe and provided a framework for translating epidemiologic evidence into policy decisions and clinical standards [6]. Giuseppe Mancia [2], with Harvard University [3] and Johns Hopkins University [5], contributed to the European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) [6]. His contributions to risk assessment and guideline development, and to translating surveillance data into prioritized preventive strategies, were instrumental in shaping policy and practice [6].

Precision Public Health era

Lisa C. Richardson [1] is a public-health scientist whose work in this era spans institutions such as the University of Toronto [3] and the University of Amsterdam [4]. Her key contributions include documenting national cancer screening test use patterns [5], highlighting colorectal cancer screening adoption differences across states [7], and synthesizing insights on how COVID-19 reshaped chronic disease prevention and care [6], underscoring the need for equity-focused, data-driven strategies in precision public health. Peter A. Briss [2] contributed to shaping prevention policy by highlighting persistent underuse of preventive services [8], clarifying health-care system dynamics during the COVID-19 era [6], and arguing for preventive investments as essential for pandemic resilience [9]. These contributions were important for the era because they supported data-driven, equity-focused, place-based prevention strategies that link policy levers and primary-care delivery to reduce disparities in chronic disease.